Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

RESPIRE 2: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis

Timothy Aksamit, Anthony De Soyza, Tiemo-Joerg Bandel, Margarita Criollo, J. Stuart Elborn, Elisabeth Operschall, Eva Polverino, Katrin Roth, Kevin L. Winthrop, Robert Wilson
European Respiratory Journal 2018 51: 1702053; DOI: 10.1183/13993003.02053-2017
Timothy Aksamit
1Mayo Clinic, Rochester, MN, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: aksamit.timothy@mayo.edu
Anthony De Soyza
2Newcastle University and Freeman Hospital, Newcastle upon Tyne, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Anthony De Soyza
Tiemo-Joerg Bandel
3Bayer AG, Wuppertal, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Margarita Criollo
4Bayer Inc., Mississauga, ON, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. Stuart Elborn
5National Heart and Lung Institute, Imperial College London and Royal Brompton Hospital, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elisabeth Operschall
6Bayer AG, Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eva Polverino
7Hospital Universitari Vall d'Hebron, Institut de Recerca Vall d'Hebron, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katrin Roth
6Bayer AG, Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kevin L. Winthrop
8Oregon Health and Science University, Portland, OR, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert Wilson
9Royal Brompton Hospital and Imperial College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 51 no. 1
DOI 
https://doi.org/10.1183/13993003.02053-2017
PubMed 
29371384

Published By 
European Respiratory Society
Print ISSN 
0903-1936
Online ISSN 
1399-3003
History 
  • Received October 6, 2017
  • Accepted November 20, 2017
  • Published online January 25, 2018.

Copyright & Usage 
Copyright ©ERS 2018

Author Information

  1. Timothy Aksamit1⇑,
  2. Anthony De Soyza2,
  3. Tiemo-Joerg Bandel3,
  4. Margarita Criollo4,
  5. J. Stuart Elborn5,
  6. Elisabeth Operschall6,
  7. Eva Polverino7,
  8. Katrin Roth6,
  9. Kevin L. Winthrop8 and
  10. Robert Wilson9
  1. 1Mayo Clinic, Rochester, MN, USA
  2. 2Newcastle University and Freeman Hospital, Newcastle upon Tyne, UK
  3. 3Bayer AG, Wuppertal, Germany
  4. 4Bayer Inc., Mississauga, ON, Canada
  5. 5National Heart and Lung Institute, Imperial College London and Royal Brompton Hospital, London, UK
  6. 6Bayer AG, Berlin, Germany
  7. 7Hospital Universitari Vall d'Hebron, Institut de Recerca Vall d'Hebron, Barcelona, Spain
  8. 8Oregon Health and Science University, Portland, OR, USA
  9. 9Royal Brompton Hospital and Imperial College London, London, UK
  1. Timothy Aksamit, Dept of Medicine, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA. E-mail: aksamit.timothy{at}mayo.edu
View Full Text

Funding

  • Bayer

Article usage

Article usage: January 2018 to December 2022

AbstractFullPdf
Jan 201888614787
Feb 2018637202143
Mar 20183838944
Apr 20181824844
May 20181612919
Jun 20181403021
Jul 2018942214
Aug 2018982615
Sep 2018792019
Oct 20181383917
Nov 201872198
Dec 20188396
Jan 20191112316
Feb 20191002528
Mar 20191241916
Apr 2019791411
May 2019401710
Jun 2019521711
Jul 2019823517
Aug 201987426
Sep 201918824
Oct 2019310140
Nov 201987838
Dec 201946434
Jan 202049036
Feb 2020106935
Mar 202045319
Apr 202037129
May 202059618
Jun 202076457
Jul 202045624
Aug 202075811
Sep 2020711037
Oct 2020118226
Nov 202037832
Dec 2020417014
Jan 202159628
Feb 202106719
Mar 202126819
Apr 202157120
May 2021812426
Jun 202136022
Jul 202174834
Aug 2021108242
Sep 20211512237
Oct 202157742
Nov 2021310531
Dec 202108213
Jan 202275821
Feb 202245226
Mar 202249338
Apr 202217622
May 202267323
Jun 202248633
Jul 202257334
Aug 202278124
Sep 2022810544
Oct 2022610532
Nov 202248937
Dec 202246519

Altmetrics

PreviousNext
Back to top
View this article with LENS
Vol 51 Issue 1 Table of Contents
European Respiratory Journal: 51 (1)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
RESPIRE 2: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
RESPIRE 2: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis
Timothy Aksamit, Anthony De Soyza, Tiemo-Joerg Bandel, Margarita Criollo, J. Stuart Elborn, Elisabeth Operschall, Eva Polverino, Katrin Roth, Kevin L. Winthrop, Robert Wilson
European Respiratory Journal Jan 2018, 51 (1) 1702053; DOI: 10.1183/13993003.02053-2017

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
RESPIRE 2: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis
Timothy Aksamit, Anthony De Soyza, Tiemo-Joerg Bandel, Margarita Criollo, J. Stuart Elborn, Elisabeth Operschall, Eva Polverino, Katrin Roth, Kevin L. Winthrop, Robert Wilson
European Respiratory Journal Jan 2018, 51 (1) 1702053; DOI: 10.1183/13993003.02053-2017
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Abstract
    • Introduction
    • Methods
    • Results
    • Discussion
    • Supplementary material
    • Disclosures
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • CF and non-CF bronchiectasis
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

Original articles

  • Identifying early PAH biomarkers in systemic sclerosis
  • Viable virus aerosol propagation by PAP circuit leak
  • Ambulatory management of secondary spontaneous pneumothorax
Show more Original articles

Bronchiectasis

  • Bronchial gene expression alterations in bronchiectasis
  • Clinical outcomes of bronchiectasis in India
  • Genome sequencing reveals underdiagnosis of PCD in bronchiectasis
Show more Bronchiectasis

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society